UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
First patient resistant to Viread found in Korea
A Korean doctor has found patients who showed resistance to Viread (compoun...
by Park Gi-taek
|
2017-06-26 13:40
라인
Pfizer vows patient access for new breast cancer drug
Pfizer Korea said Friday the company would do its utmost to ensure patient ...
by Constance Williams
|
2017-06-23 13:04
라인
Roche, Celgene fight for No. 1 spot in oncology market
EvaluatePharma, which analyzes pharmaceuticals and biotech companies, said ...
by Marian Chu
|
2017-06-23 11:54
라인
CSL Behring gets FDA approval for rare genetic disease drug
The U.S. Food and Drug Administration Thursday approved Haegarda, CSL Behri...
by Marian Chu
|
2017-06-23 11:44
라인
Why Roche Korea can’t unveil research results of new lung cancer therapy?
Roche Korea is treading carefully in promoting Alecensa (compound: alectini...
by Nam Doo-hyun
|
2017-06-22 16:36
라인
Is Pfizer discriminating against Korean consumers?
Pfizer has come under fire in Korea, as a group of breast cancer patients c...
by Constance Williams
|
2017-06-21 17:17
라인
Hanmi’s R&D workforce increases 9 times in 3 years
Job creation has grown explosively in Hanmi Pharmaceutical’s research and d...
by Marian Chu
|
2017-06-21 15:59
라인
JW Pharmaceutical’s Actemra top choice for rheumatoid arthritis
JW Pharmaceutical said Wednesday that Actemra (Ingredient name: Tosylchemum...
by Constance Williams
|
2017-06-21 14:24
라인
Sanofi fuels competition in 4-strain flu vaccine market
Competition in the quadrivalent influenza vaccine market will likely become...
by Nam Doo-hyun
|
2017-06-21 11:36
라인
Kwangdong tops pharmaceuticals’ 1Q sales list of health food
Kwangdong Pharmaceutical has recorded the highest sales of functional healt...
by Nam Doo-hyun
|
2017-06-20 18:47
라인
New drug to treat glaucoma to hit market soon
DE-117, a new glaucoma therapy being developed by Santen Pharmaceutical산텐제약...
by Lee Hye-seon
|
2017-06-20 16:30
라인
GSK conducts clinical trials for Rotarix without PCV
GlaxoSmithKline (GSK) will conduct clinical trials in Korea of its Rotaviru...
by Lee Hye-seon
|
2017-06-20 12:48
라인
Celltrion’s lymphoma drug proves 97% tumor response rate
The European Phase III trial results for Celltrion’s follicular lymphoma dr...
by Marian Chu
|
2017-06-15 12:38
라인
Orum secures $8 million to develop cell-penetrating antibody technology
Orum Therapeutics, a biotech business, said Wednesday it had received $8 mi...
by Marian Chu
|
2017-06-15 11:25
라인
Pharmaceutical industry wants to use medical big data at public organizations
Drugmakers are raising their voices to ease regulations so that they can ma...
by Nam Doo-hyun
|
2017-06-14 15:46
라인
Novo Nordisk supports people with diabetes through Tour de Korea
Novo Nordisk Pharma employees in Korea hold an in-house support event for T...
by Constance Williams
|
2017-06-14 11:25
라인
Pharmaceutical industry shows low satisfaction with government policy
Korea’s pharmaceutical and biotechnology industries have cited the governme...
by Lee Hye-seon
|
2017-06-13 18:39
라인
US watchdogs take note of corruption in Korean pharmaceuticals
The criminal and civil charges brought against Novartis Korea have directed...
by Marian Chu
|
2017-06-13 16:42
라인
Daewoong hurries to add indications for botox product
Daewoong Pharmaceutical is going all out to add indications to its botulinu...
by Lee Hye-seon
|
2017-06-13 15:51
라인
FTC imposes penalty of W500 million on Novartis Korea
Fair Trade Commission has slapped 500 million won ($440,000) in fines and i...
by Lee Hye-seon
|
2017-06-12 16:39
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top